Table 2.
Statistical approach | Target patient population | Advantages | Disadvantages |
---|---|---|---|
Survivors analysis | Patients who survive in each treatment group | - Simple to compute - If mortality is independent of treatment, provides an estimate of the causal effect of the treatment on the always survivors |
- If the effect of the treatment is to sustain frail patients, then the estimated treatment effect is a biased estimate of the causal effect of the treatment on the always survivors and may be misleading - Randomization is not guaranteed to be preserved within the subset of survivors - Does not include all randomized patients, violating the intention to treat principle for randomized trials |
Survivor average causal effect (SACE) | Always survivors—that is, patients who would survive regardless of which treatment they receive | - Estimates the causal effect of the treatment on the functional outcome among always survivors - Randomization is preserved within the subset of always survivors so the comparison of randomized treatment groups is unbiased - When the intervention does not affect mortality, SACE is identified from the observed data (ie, all survivors are always survivors) without making any untestable assumptions |
- Comparison of the functional outcome is made among a subset of patients (ie, those who would survive regardless of which treatment they received) that is not directly identifiable - Requires eliciting expert opinion on assumptions that are not testable within the observed data (eg, there are no patients who would survive under control but who would die under intervention) - Does not include all randomized patients, violating the intention to treat principle for randomized trials |
Composite endpoint | All randomized patients | - Simple to compute (both quantiles of and the rank statistic for the distribution of the composite outcome) - All randomized patients are included in the analysis, consistent with the intention to treat principle - Randomization is preserved so the comparison of randomized treatment groups is unbiased - Provides a hypothesis test for comparing the distribution or a specific quantile (eg, median) of the composite endpoint across treatment groups that has a causal interpretation - The distribution of the composite endpoint in each treatment group can be examined to identify if treatment groups differ in mortality and/or the functional outcome |
- Requires eliciting expert opinion on ordering mortality and the functional outcome - The size of the rank statistic may be difficult to interpret |